These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Noninvasive Markers of Portal Hypertension Detect Decompensation in Overweight or Obese Patients With Compensated Advanced Chronic Liver Disease. Mendoza Y; Cocciolillo S; Murgia G; Chen T; Margini C; Sebastiani G; Berzigotti A Clin Gastroenterol Hepatol; 2020 Dec; 18(13):3017-3025.e6. PubMed ID: 32289534 [TBL] [Abstract][Full Text] [Related]
9. Dynamics in Liver Stiffness Measurements Predict Outcomes in Advanced Chronic Liver Disease. Semmler G; Yang Z; Fritz L; Köck F; Hofer BS; Balcar L; Hartl L; Jachs M; Stopfer K; Schedlbauer A; Neumayer D; Maurer J; Müllner-Bucsics T; Simbrunner B; Scheiner B; Trauner M; Mandorfer M; Reiberger T; Bauer DJM Gastroenterology; 2023 Oct; 165(4):1041-1052. PubMed ID: 37442301 [TBL] [Abstract][Full Text] [Related]
10. Systemic inflammation increases across distinct stages of advanced chronic liver disease and correlates with decompensation and mortality. Costa D; Simbrunner B; Jachs M; Hartl L; Bauer D; Paternostro R; Schwabl P; Scheiner B; Stättermayer AF; Pinter M; Trauner M; Mandorfer M; Reiberger T J Hepatol; 2021 Apr; 74(4):819-828. PubMed ID: 33075344 [TBL] [Abstract][Full Text] [Related]
11. CHESS-ALARM score to stratify decompensation risk in compensated advanced chronic liver disease patients: An international multicenter study. Wong YJ; Li J; Liu C; Chen Z; Chan YH; Putera M; Teh KB; Ang TL; Zhao L; Yan Z; Kumar R; Li X; Qi X J Gastroenterol Hepatol; 2022 Jun; 37(6):1043-1051. PubMed ID: 35253271 [TBL] [Abstract][Full Text] [Related]
12. Prognostic Significance of Controlled Attenuation Parameter in Patients With Compensated Advanced Chronic Liver Disease. Margini C; Murgia G; Stirnimann G; De Gottardi A; Semmo N; Casu S; Bosch J; Dufour JF; Berzigotti A Hepatol Commun; 2018 Aug; 2(8):929-940. PubMed ID: 30094404 [TBL] [Abstract][Full Text] [Related]
13. Good performance of liver stiffness measurement in the prediction of postoperative hepatic decompensation in patients with cirrhosis complicated with hepatocellular carcinoma. Procopet B; Fischer P; Horhat A; Mois E; Stefanescu H; Comsa M; Graur F; Bartos A; Lupsor-Platon M; Badea R; Grigorescu M; Tantau M; Sparchez Z; Al Hajjar N Med Ultrason; 2018 Aug; 20(3):272-277. PubMed ID: 30167578 [TBL] [Abstract][Full Text] [Related]
14. Liver stiffness predicts clinical outcome in human immunodeficiency virus/hepatitis C virus-coinfected patients with compensated liver cirrhosis. Merchante N; Rivero-Juárez A; Téllez F; Merino D; José Ríos-Villegas M; Márquez-Solero M; Omar M; Macías J; Camacho A; Pérez-Pérez M; Gómez-Mateos J; Rivero A; Antonio Pineda J; Hepatology; 2012 Jul; 56(1):228-38. PubMed ID: 22278746 [TBL] [Abstract][Full Text] [Related]
15. Monitoring Occurrence of Liver-Related Events and Survival by Transient Elastography in Patients With Nonalcoholic Fatty Liver Disease and Compensated Advanced Chronic Liver Disease. Petta S; Sebastiani G; Viganò M; Ampuero J; Wai-Sun Wong V; Boursier J; Berzigotti A; Bugianesi E; Fracanzani AL; Cammà C; Enea M; Grottes MD; Di Marco V; Younes R; Keyrouz A; Mazzola S; Mendoza Y; Pennisi G; Romero-Gomez M; Craxì A; de Ledinghen V Clin Gastroenterol Hepatol; 2021 Apr; 19(4):806-815.e5. PubMed ID: 32621970 [TBL] [Abstract][Full Text] [Related]
16. Post-treatment LSM rather than change during treatment predicts decompensation in patients with cACLD after HCV cure. Semmler G; Alonso López S; Pons M; Lens S; Dajti E; Griemsmann M; Zanetto A; Burghart L; Hametner-Schreil S; Hartl L; Manzano M; Rodriguez-Tajes S; Zanaga P; Schwarz M; Gutierrez ML; Jachs M; Pocurull A; Polo B; Ecker D; Mateos B; Izquierdo S; Real Y; Ahumada A; Bauer DJM; Mauz JB; Casanova-Cabral M; Gschwantler M; Russo FP; Azzaroli F; Maasoumy B; Reiberger T; Forns X; Genesca J; Bañares R; Mandorfer M; J Hepatol; 2024 Jul; 81(1):76-83. PubMed ID: 38521170 [TBL] [Abstract][Full Text] [Related]
17. Role of magnetic resonance elastography in compensated and decompensated liver disease. Asrani SK; Talwalkar JA; Kamath PS; Shah VH; Saracino G; Jennings L; Gross JB; Venkatesh S; Ehman RL J Hepatol; 2014 May; 60(5):934-9. PubMed ID: 24362072 [TBL] [Abstract][Full Text] [Related]
18. The impact of hepatic steatosis on portal hypertension. Semmler G; Scheiner B; Schwabl P; Bucsics T; Paternostro R; Chromy D; Stättermayer AF; Trauner M; Mandorfer M; Ferlitsch A; Reiberger T PLoS One; 2019; 14(11):e0224506. PubMed ID: 31693695 [TBL] [Abstract][Full Text] [Related]
19. Liver stiffness measurement by magnetic resonance elastography predicts cirrhosis and decompensation in alcohol-related liver disease. Chen J; Xu P; Kalutkiewicz K; Sheng Y; Warsame F; Tahboub-Amawi MA; Li J; Wang J; Venkatesh SK; Ehman RL; Shah VH; Simonetto DA; Yin M Abdom Radiol (NY); 2024 Jul; 49(7):2231-2241. PubMed ID: 39023567 [TBL] [Abstract][Full Text] [Related]
20. Changes in Liver Stiffness, Measured by Magnetic Resonance Elastography, Associated With Hepatic Decompensation in Patients With Primary Sclerosing Cholangitis. Eaton JE; Sen A; Hoodeshenas S; Schleck CD; Harmsen WS; Gores GJ; LaRusso NF; Gossard AA; Lazaridis KN; Venkatesh SK Clin Gastroenterol Hepatol; 2020 Jun; 18(7):1576-1583.e1. PubMed ID: 31683058 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]